Cost-Benefit Analysis of the FDA: The Case of the Prescription Drug User Fee Acts - Tomas J. Philipson; Ernst R. Berndt; Adrian H. B. Gottschalk; Eric Sun (The University of Chicago, George J. Stigler Center for the Study of the Economy and the State, 2007)
Keywords: 330